
In recent years, zzso zzso zzso zzso has emerged as a novel oral platinum analogue with a better toxicity profile than zzso Since zzso is more zzso than zzso or zzso it appears to demonstrate efficacy in zzso cell zzso The zzso and clinical evaluation of zzso zzso this review of the pharmacology and clinical trial data of this zzso 

A literature review was conducted in the zzso database from 1985 to present using the zzso zzso or zzso The abstracts regarding zzso reported at the 2007 - 2009 American Society of Clinical Oncology meetings were also zzso 

zzso has a favorable toxicity profile, and appears to have clinical activity against a variety of zzso such as breast, prostate and lung zzso The oral route of administration and the intermittent schedule makes it very convenient for clinical zzso Despite this, a zzso indication has not yet been zzso The only Phase III trial with zzso was conducted in zzso zzso zzso prostate cancer zzso revealing an improvement in zzso survival but no overall survival zzso Future development would have to include designing trials in zzso zzso zzso or in other zzso where zzso is of zzso 

